Skip to main content
Caplight Logo









ProteinQure

ProteinQure

Private
TorontoHealthcare & Life Scienceshttps://www.proteinqure.com/

Last Round

Grant

May 27, 2026

Total Funding Raised

$19.02M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ProteinQure is a biotechnology company that has developed a computational platform for the design of peptide-based therapeutics using quantum computing, artificial intelligence, and molecular dynamics simulations.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Quantum Computing, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

peptide drug discoveryAI drug discoverypeptide therapeuticsAI biotechAI-first biotechcomputational drug designpeptide-drug conjugatesin silico drug designmolecular simulationbiotech R&Dquantum computingdrug discovery platformpharma partnershipsoncology therapeuticsdrug discovery pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProteinQure Comparables

Compare ProteinQure with similar companies based on industry and business-model similarity.

ProteinQure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Unnatural Products
88%
Pepticom
84%
Syneron Bio
82%

ProteinQure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 27, 2026
GrantApr 7, 2026
Series AMay 28, 2025
GrantJan 21, 2025
GrantFeb 22, 2024
Seed
Jul 25, 2019

Key People

Founding team and executive leadership

Christopher Ing

Co-Founder And Chief Scientific Officer

Founding Team

Mark Fingerhuth

Co-Founder And Chief R D Officer

Founding Team

Tomas Babej

Cofounder and Chief Technology Officer

Founding Team

Lucas Siow

Co-Founder - CEO

Founding Team

ProteinQure Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    $1.31M grant from Federal Economic Development Agency for Southern Ontario

  • Apr 7, 2026

    $1.86M grant received

ProteinQure Filings

Explore SEC and related filing metadata, where available.

ProteinQure filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ProteinQure's valuation, stock price, and market status.

Is ProteinQure a public or private company?

ProteinQure is a private company.

What is the current stock price of ProteinQure?

ProteinQure is a private company with no public stock price. No recent secondary market data is available.

How much is ProteinQure worth (valuation)?

Valuation information for ProteinQure is not publicly available.

Can I buy ProteinQure stock?

ProteinQure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ProteinQure's last funding round?

ProteinQure's most recent funding round was Grant on April 7, 2026.

Who are the main investors in ProteinQure?

Key investors in ProteinQure include Heron Rock Fund, Felicis Ventures.

Will ProteinQure IPO soon?

No public IPO plans have been announced for ProteinQure.

How can I track ProteinQure secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ProteinQure's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersToronto
Employee Range28
Year Founded2017
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?